J. David Joyner - 28 Feb 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ J. David Joyner
Issuer symbol
CVS
Transactions as of
28 Feb 2023
Net transactions value
+$1,999,948
Form type
4
Filing time
01 Mar 2023, 16:11:34 UTC
Previous filing
03 Feb 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (Restricted) Award $1,999,948 +23,940 $83.54 23,940 28 Feb 2023 Direct F1
holding CVS Common Stock 34,672 28 Feb 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 2/28/2024.